Study on the application effect of photobiomodulation therapy in patients with radiation dermatitis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300077854

Enrollment

Unknown

Registered

2023-11-22

Start date

2022-10-18

Completion date

Unknown

Last updated

2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Radiation Dermatitis

Interventions

Interventional group:Photobiomodulation therapy

Control group:Conventional treatment

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age = 18 years; acute radiation dermatitis; first radiotherapy; total radiotherapy dose = 40 Gy; plain language; signed informed consent

Exclusion criteria

Exclusion criteria: Severe cardiac, hepatic, pulmonary and renal dysfunction; pre-existing skin problems in the treatment area, e.g. sinus tracts, cannulae, etc.; patients who are unable to cooperate with treatment.

Design outcomes

Primary

Measure	Time frame
Radiation dermatitis grading;	—

Secondary

Measure	Time frame
Quality of life;Pain;	—

Countries

China

Contacts

Public ContactXiangyu Liu

Hunan Cancer Hospital

979596459@qq.com+86 136 2741 0728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026